Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Male pattern baldness does not cause an increased risk of prostate cancer.

Finasteride reduces prostate size and PSA levels in young patients.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride may improve prostate cancer treatment outcomes.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.